These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 23948943)

  • 21. Two mouse models of Alzheimer's disease accumulate amyloid at different rates and have distinct Aβ oligomer profiles unaltered by ablation of cellular prion protein.
    Purro SA; Farmer M; Noble E; Sarell CJ; Powell M; Yip D; Giggins L; Zakka L; Thomas DX; Farrow M; Nicoll AJ; Walsh D; Collinge J
    PLoS One; 2023; 18(11):e0294465. PubMed ID: 37976283
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The case for soluble Aβ oligomers as a drug target in Alzheimer's disease.
    Hefti F; Goure WF; Jerecic J; Iverson KS; Walicke PA; Krafft GA
    Trends Pharmacol Sci; 2013 May; 34(5):261-6. PubMed ID: 23582316
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunization with either prion protein fragment 95-123 or the fragment-specific antibodies rescue memory loss and neurodegenerative phenotype of neurons in olfactory bulbectomized mice.
    Bobkova NV; Medvinskaya NI; Kamynina AV; Aleksandrova IY; Nesterova IV; Samokhin AN; Koroev DO; Filatova MP; Nekrasov PV; Abramov AY; Leonov SV; Volpina OM
    Neurobiol Learn Mem; 2014 Jan; 107():50-64. PubMed ID: 24239620
    [TBL] [Abstract][Full Text] [Related]  

  • 24. β-amyloid oligomers and prion protein: Fatal attraction?
    Forloni G; Balducci C
    Prion; 2011; 5(1):10-5. PubMed ID: 21150333
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amyloid-beta oligomers increase the localization of prion protein at the cell surface.
    Caetano FA; Beraldo FH; Hajj GN; Guimaraes AL; Jürgensen S; Wasilewska-Sampaio AP; Hirata PH; Souza I; Machado CF; Wong DY; De Felice FG; Ferreira ST; Prado VF; Rylett RJ; Martins VR; Prado MA
    J Neurochem; 2011 May; 117(3):538-53. PubMed ID: 21352228
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sialylated glycosylphosphatidylinositols suppress the production of toxic amyloid-β oligomers.
    Nolan W; McHale-Owen H; Bate C
    Biochem J; 2017 Aug; 474(17):3045-3058. PubMed ID: 28729427
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cellular prion protein mediates the toxicity of beta-amyloid oligomers: implications for Alzheimer disease.
    Nygaard HB; Strittmatter SM
    Arch Neurol; 2009 Nov; 66(11):1325-8. PubMed ID: 19901162
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of Alkaline Phosphatase-Fused Mouse Prion Protein and Its Application in Toxic Aβ Oligomer Detection.
    Tsukakoshi K; Kubo R; Ikebukuro K
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36498917
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Accumulation of cellular prion protein within β-amyloid oligomer plaques in aged human brains.
    Takahashi RH; Yokotsuka M; Tobiume M; Sato Y; Hasegawa H; Nagao T; Gouras GK
    Brain Pathol; 2021 Sep; 31(5):e12941. PubMed ID: 33624334
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aβ induces its own prion protein N-terminal fragment (PrPN1)-mediated neutralization in amorphous aggregates.
    Béland M; Bédard M; Tremblay G; Lavigne P; Roucou X
    Neurobiol Aging; 2014 Jul; 35(7):1537-48. PubMed ID: 24602510
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oligomeric Aβ-induced synaptic dysfunction in Alzheimer's disease.
    Tu S; Okamoto S; Lipton SA; Xu H
    Mol Neurodegener; 2014 Nov; 9():48. PubMed ID: 25394486
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prions and Neurodegenerative Diseases: A Focus on Alzheimer's Disease.
    Crestini A; Santilli F; Martellucci S; Carbone E; Sorice M; Piscopo P; Mattei V
    J Alzheimers Dis; 2022; 85(2):503-518. PubMed ID: 34864675
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alzheimer's amyloid-β oligomers rescue cellular prion protein induced tau reduction via the Fyn pathway.
    Chen RJ; Chang WW; Lin YC; Cheng PL; Chen YR
    ACS Chem Neurosci; 2013 Sep; 4(9):1287-96. PubMed ID: 23805846
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synaptic changes in Alzheimer's disease and its models.
    Pozueta J; Lefort R; Shelanski ML
    Neuroscience; 2013 Oct; 251():51-65. PubMed ID: 22687952
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alzheimer's disease brain-derived amyloid-β-mediated inhibition of LTP in vivo is prevented by immunotargeting cellular prion protein.
    Barry AE; Klyubin I; Mc Donald JM; Mably AJ; Farrell MA; Scott M; Walsh DM; Rowan MJ
    J Neurosci; 2011 May; 31(20):7259-63. PubMed ID: 21593310
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cellular prion protein targets amyloid-β fibril ends via its C-terminal domain to prevent elongation.
    Bove-Fenderson E; Urano R; Straub JE; Harris DA
    J Biol Chem; 2017 Oct; 292(41):16858-16871. PubMed ID: 28842494
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Zhang W; Hao J; Liu R; Zhang Z; Lei G; Su C; Miao J; Li Z
    Behav Brain Res; 2011 Sep; 222(2):342-50. PubMed ID: 21513747
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LPYFDa neutralizes amyloid-beta-induced memory impairment and toxicity.
    Granic I; Masman MF; Kees Mulder C; Nijholt IM; Naude PJ; de Haan A; Borbély E; Penke B; Luiten PG; Eisel UL
    J Alzheimers Dis; 2010; 19(3):991-1005. PubMed ID: 20157254
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alzheimer's therapeutics targeting amyloid beta 1-42 oligomers II: Sigma-2/PGRMC1 receptors mediate Abeta 42 oligomer binding and synaptotoxicity.
    Izzo NJ; Xu J; Zeng C; Kirk MJ; Mozzoni K; Silky C; Rehak C; Yurko R; Look G; Rishton G; Safferstein H; Cruchaga C; Goate A; Cahill MA; Arancio O; Mach RH; Craven R; Head E; LeVine H; Spires-Jones TL; Catalano SM
    PLoS One; 2014; 9(11):e111899. PubMed ID: 25390692
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabotropic glutamate receptor 5 is a coreceptor for Alzheimer aβ oligomer bound to cellular prion protein.
    Um JW; Kaufman AC; Kostylev M; Heiss JK; Stagi M; Takahashi H; Kerrisk ME; Vortmeyer A; Wisniewski T; Koleske AJ; Gunther EC; Nygaard HB; Strittmatter SM
    Neuron; 2013 Sep; 79(5):887-902. PubMed ID: 24012003
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.